Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312382020> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4312382020 endingPage "22" @default.
- W4312382020 startingPage "14" @default.
- W4312382020 abstract "Abstract. Selection of adequate therapy for bronchial asthma (BA) by a doctor directly affects not only the level of control over the patient’s symptoms, his compliance, but also improves the patient’s quality of life and avoids his disability. Doctors and patients are already accustomed to the fact that inhaled glucocorticosteroids (ICS) are the most effective anti-inflammatory drugs for the treatment of asthma. However, the response to ICS varies among patients, so some may require a medium-dose ICS if their asthma is not controlled or if they have asthma exacerbations. Among the existing following fixed combinations of ICS/ long-acting β2 -agonists (LABA), which are approved for regular use from the 3rd step of BA treatment, only two are currently available in Ukraine — budesonide + formoterol and fluticasone propionate + salmeterol. GINA recommends the use of an ICS/formoterol combination as the preferred single maintenance and palliative therapy because studies have shown that use of this therapy as a patient-initiated symptomatic palliative therapy when symptoms worsen provides comparable benefit to short-acting β2 -agonists (SABA) for the relief of smooth muscle dysfunction. in addition to providing corticosteroids with an increase in local protection in case of increased inflammation of the respiratory tract Budesonide/formoterol fixed-dose single-inhaler therapy for basic therapy and symptom relief helps achieve the main goals of AD treatment, namely achieving symptom control and reducing future risks, fully consistent with the latest GINA guidelines. This regimen, in comparison with alternative regimens of therapy with fixed doses of other combined drugs and SABA as needed, reduces the risk of exacerbations, gives a lower steroid burden on the patient with a comparable level of BA control." @default.
- W4312382020 created "2023-01-04" @default.
- W4312382020 creator A5009520150 @default.
- W4312382020 creator A5040310093 @default.
- W4312382020 creator A5043695354 @default.
- W4312382020 creator A5043835666 @default.
- W4312382020 date "2022-01-01" @default.
- W4312382020 modified "2023-10-17" @default.
- W4312382020 title "Effectiveness and Safety of Therapy of Patients with Bronchial Asthma using a Single Inhaler" @default.
- W4312382020 doi "https://doi.org/10.31655/2307-3373-2022-4-14-22" @default.
- W4312382020 hasPublicationYear "2022" @default.
- W4312382020 type Work @default.
- W4312382020 citedByCount "0" @default.
- W4312382020 crossrefType "journal-article" @default.
- W4312382020 hasAuthorship W4312382020A5009520150 @default.
- W4312382020 hasAuthorship W4312382020A5040310093 @default.
- W4312382020 hasAuthorship W4312382020A5043695354 @default.
- W4312382020 hasAuthorship W4312382020A5043835666 @default.
- W4312382020 hasBestOaLocation W43123820201 @default.
- W4312382020 hasConcept C126322002 @default.
- W4312382020 hasConcept C177713679 @default.
- W4312382020 hasConcept C2776042228 @default.
- W4312382020 hasConcept C2776136866 @default.
- W4312382020 hasConcept C2776719499 @default.
- W4312382020 hasConcept C2776999253 @default.
- W4312382020 hasConcept C2777450039 @default.
- W4312382020 hasConcept C2779028295 @default.
- W4312382020 hasConcept C2779871671 @default.
- W4312382020 hasConcept C2780261241 @default.
- W4312382020 hasConcept C2909086917 @default.
- W4312382020 hasConcept C71924100 @default.
- W4312382020 hasConceptScore W4312382020C126322002 @default.
- W4312382020 hasConceptScore W4312382020C177713679 @default.
- W4312382020 hasConceptScore W4312382020C2776042228 @default.
- W4312382020 hasConceptScore W4312382020C2776136866 @default.
- W4312382020 hasConceptScore W4312382020C2776719499 @default.
- W4312382020 hasConceptScore W4312382020C2776999253 @default.
- W4312382020 hasConceptScore W4312382020C2777450039 @default.
- W4312382020 hasConceptScore W4312382020C2779028295 @default.
- W4312382020 hasConceptScore W4312382020C2779871671 @default.
- W4312382020 hasConceptScore W4312382020C2780261241 @default.
- W4312382020 hasConceptScore W4312382020C2909086917 @default.
- W4312382020 hasConceptScore W4312382020C71924100 @default.
- W4312382020 hasIssue "4" @default.
- W4312382020 hasLocation W43123820201 @default.
- W4312382020 hasOpenAccess W4312382020 @default.
- W4312382020 hasPrimaryLocation W43123820201 @default.
- W4312382020 hasRelatedWork W1970048937 @default.
- W4312382020 hasRelatedWork W1985655856 @default.
- W4312382020 hasRelatedWork W2005698822 @default.
- W4312382020 hasRelatedWork W2024265404 @default.
- W4312382020 hasRelatedWork W2086416159 @default.
- W4312382020 hasRelatedWork W2087002740 @default.
- W4312382020 hasRelatedWork W2407210537 @default.
- W4312382020 hasRelatedWork W2467813600 @default.
- W4312382020 hasRelatedWork W2621439852 @default.
- W4312382020 hasRelatedWork W4312382020 @default.
- W4312382020 isParatext "false" @default.
- W4312382020 isRetracted "false" @default.
- W4312382020 workType "article" @default.